What's New

Chart of Evidence-Based Screening Tools and Assessments for Adults and Adolescents

The National Institute on Drug Abuse (NIDA) Clinical Trials Network has updated (June 2018) scientifically validated, online screening tools designed to assess a patient's risk for substance misuse and substance use disorder. The tool also assists health care providers with prevention and treatment strategies [LINK].

Mentorship Program Available Free

With a goal of building MAT capacity among rural primary care providers, we'd like to introudce physician mentors who are available to help answer your questions. Physician mentors include: Dr. William Yarborough, Dr. Layne Subera and Dr. Paul Seale. 
You can find a consulting request form here [LINK].

Tracking Our Progress

One year after the first set of trainings, 18 of our 46 participating providers have obtained their buprenorphine waiver across 15 counties through the Rural Oklahoma MAT Project. We are more than a quarter of the way to our goal of 68 waivered providers across 42 eligible rural Oklahoma counties. Thank you for your support, and please help spread the news about our work!

Welcome

Welcome to the Oklahoma Medication-Assisted Treatment (MAT) Expansion Project. This project aims to expand access to MAT for persons with opioid use disorder (OUD) by training and supporting rural primary care practices in Oklahoma. Medication-Assisted Treatment is an evidence-based strategy for treating persons with OUD. MAT combines the use of medications with counseling and behavior therapies to provide a whole-patient approach to treatment.

About Oklahoma Rural MAT Expansion

The Problem

Prescription drug overdoses kill nearly two Oklahomans per day.
In many rural Oklahoma counties, opioids account for more than half of drug overdose deaths.
Oklahoma lacks access to treatment for OUD, particularly in rural areas where there are few primary care
providers trained to identify and treat people who are opioid dependent. Many Oklahoma providers are
concerned about the devastating effect on their patients and communities.
However, many providers also feel overwhelmed at the prospect of offering treatment for OUD in their own practice.
Click here for more information about opioid addiction in Oklahoma.

What We Offer

We offer practical, hands-on assistance to you and your office team through training, case-based
consultations with addiction specialists, and mentoring from experienced medication-assisted treatment providers.
Primary care physicians, nurse practitioners and physician assistants can receive certification and appropriate
waivers to treat and manage opioid dependent patients in the office setting. Practices will receive a stipend to
facilitate data collection for a planned evaluation of the project.

Find out if your practice is eligible to participate.

Who is offering this program?

The American Institutes for Research (AIR) is leading this project in partnership
with the state of Oklahoma, the ECHO Institute at the University of New Mexico
Health Sciences Center, and the American Society of Addiction Medicine. This
project is supported by grant R18HS025067 from the Agency for Healthcare
Research and Quality, an agency of the U.S. Department of Health and Human
Services. (Click here to learn more about partners )


Contact Us


Join Today! To complete our brief eligibility screening form, please visit
https://www.surveymonkey.com/r/OklahomaMAT

Want to learn more about the project? If you'd like to listen to a recording of our informational webinar, entitled "Medication-Assisted Treatment in Rural Oklahoma," please follow this link.

Sign up for an informational webinar with the project team and our consulting physicians.


If you have any questions, please contact the AIR team at:
OklahomaMAT@air.org
or, Phone: 866-236-4285

This project is supported by grant number R18HS025067 from the Agency for Healthcare Research and Quality, an agency of the U.S. Department of Health and Human Services. The content of this website is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.